News Novo Nordisk Foundation pledges €736m for European biotech Novo Nordisk Foundation is pumping funding into a Copenhagen-based biotech incubator, seeking to address the challenge of funding access in Europe.
News Novo Nordisk's chairman quits amid Foundation row Novo Nordisk's chairman Helge Lund will step down next month under pressure from the group's controlling shareholder, the Novo Nordisk Foundation.
News Novo Nordisk Foundation gives $75m for R&D 'challenges' The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.
News Novo Nordisk's dropping share price spells the end for CEO Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
R&D Partner Content Novo Nordisk seeks to target heart disease with Cardior acqu... Cardior CSO will speak at the Oligonucleotide Therapeutics and Delivery conference following announcement of a buyout by Novo Nordisk to enhance their
News Top charities team up with $300m for climate, health equity The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellb
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.